These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31348877)

  • 1. Break Check: Transcription-Driven Topoisomerase II Collisions near Chromatin Loop Anchors Are Hotspots for DNA Damage and Translocations.
    Uusküla-Reimand L; Wilson MD
    Mol Cell; 2019 Jul; 75(2):203-205. PubMed ID: 31348877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
    Deng S; Yan T; Jendrny C; Nemecek A; Vincetic M; Gödtel-Armbrust U; Wojnowski L
    BMC Cancer; 2014 Nov; 14():842. PubMed ID: 25406834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untangling the roles of TOP2A and TOP2B in transcription and cancer.
    Uusküla-Reimand L; Wilson MD
    Sci Adv; 2022 Nov; 8(44):eadd4920. PubMed ID: 36322662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1.
    Smith KA; Cowell IG; Zhang Y; Sondka Z; Austin CA
    Genes Chromosomes Cancer; 2014 Feb; 53(2):117-28. PubMed ID: 24327541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial Chromosome Folding and Active Transcription Drive DNA Fragility and Formation of Oncogenic MLL Translocations.
    Gothe HJ; Bouwman BAM; Gusmao EG; Piccinno R; Petrosino G; Sayols S; Drechsel O; Minneker V; Josipovic N; Mizi A; Nielsen CF; Wagner EM; Takeda S; Sasanuma H; Hudson DF; Kindler T; Baranello L; Papantonis A; Crosetto N; Roukos V
    Mol Cell; 2019 Jul; 75(2):267-283.e12. PubMed ID: 31202576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To Break or Not to Break: The Role of TOP2B in Transcription.
    Cowell IG; Casement JW; Austin CA
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase 2β and DNA topology during B cell development.
    Papapietro O; Nejentsev S
    Front Immunol; 2022; 13():982870. PubMed ID: 36045673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
    Lok CN; Lang AJ; Mirski SE; Cole SP
    Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anchoring Chromatin Loops to Cancer.
    Fowler F; Tyler JK
    Dev Cell; 2017 Aug; 42(3):209-211. PubMed ID: 28787588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural organization of the human TOP2A and TOP2B genes.
    Lang AJ; Mirski SE; Cummings HJ; Yu Q; Gerlach JH; Cole SP
    Gene; 1998 Oct; 221(2):255-66. PubMed ID: 9795238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation.
    Shapiro AB; Austin CA
    Anal Biochem; 2014 Mar; 448():23-9. PubMed ID: 24309019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chromatin remodeling complex regulates topoisomerase IIα function.
    Cancer Discov; 2013 Jul; 3(7):OF33. PubMed ID: 23847378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.
    Ju BG; Lunyak VV; Perissi V; Garcia-Bassets I; Rose DW; Glass CK; Rosenfeld MG
    Science; 2006 Jun; 312(5781):1798-802. PubMed ID: 16794079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide prediction of topoisomerase IIβ binding by architectural factors and chromatin accessibility.
    Martínez-García PM; García-Torres M; Divina F; Terrón-Bautista J; Delgado-Sainz I; Gómez-Vela F; Cortés-Ledesma F
    PLoS Comput Biol; 2021 Jan; 17(1):e1007814. PubMed ID: 33465072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations.
    Ahuja HG; Felix CA; Aplan PD
    Genes Chromosomes Cancer; 2000 Oct; 29(2):96-105. PubMed ID: 10959088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15).
    Nebral K; Schmidt HH; Haas OA; Strehl S
    Clin Cancer Res; 2005 Sep; 11(18):6489-94. PubMed ID: 16166424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
    Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
    Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide TOP2A DNA cleavage is biased toward translocated and highly transcribed loci.
    Yu X; Davenport JW; Urtishak KA; Carillo ML; Gosai SJ; Kolaris CP; Byl JAW; Rappaport EF; Osheroff N; Gregory BD; Felix CA
    Genome Res; 2017 Jul; 27(7):1238-1249. PubMed ID: 28385713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
    Menendez JA; Vellon L; Lupu R
    Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer Chemotherapy.
    Atwal M; Lishman EL; Austin CA; Cowell IG
    Mol Pharmacol; 2017 Jan; 91(1):49-57. PubMed ID: 27974636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.